Dietary oats and modulation of atherogenic pathways

Molecular Nutrition and Food Research

Volumn 56, Issue 7, 2012, Pages 1003-1013

  Andersson, Kristina E ^a   Hellstrand, Per ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; Beta glucans; Cardiovascular disease; Cholesterol; Inflammation

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; HYPOCHOLESTEROLEMIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; DIET THERAPY; FUNCTIONAL FOOD; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOLOGY; OAT; PATHOPHYSIOLOGY; PHYSIOLOGY; PLANT SEED; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; ATHEROSCLEROSIS; AVENA SATIVA; ENDOTHELIUM, VASCULAR; FUNCTIONAL FOOD; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; SEEDS;

ANIMALIA; AVENA;

EID: 84863543188     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100706     Document Type: Review

References (82)

1. Ripsin, C. M., Keenan, J. M., Jacobs, D. R., Jr., Elmer, P. J., et al., Oat products and lipid lowering. A meta-analysis. JAMA 1992, 267, 3317-3325.
2. Kerckhoffs, D. A., Brouns, F., Hornstra, G., Mensink, R. P., Effects on the human serum lipoprotein profile of beta-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. J. Nutr. 2002, 132, 2494-2505.
3. Tiwari, U., Cummins, E., Meta-analysis of the effect of beta-glucan intake on blood cholesterol and glucose levels. Nutrition 2011, 27, 1008-1016.
4. FDA, FDA allows whole oat foods to make health claim on reducing the risk of heart disease. FDA Talk Paper, T97-5, January 21, 1997.
5. European Food Safety Authority (EFSA). Scientific Opinion on the substantiation of health claims related to beta-glucans and maintenance of normal blood cholesterol concentrations (ID 754, 757, 801, 1465, 2934) and maintenance or achievement of a normal body weight (ID 820, 823) pursuant to Article 13(1) of Regulation (EC) No 1924/2006., accessed September 2010.
6. Lusis, A. J., Atherosclerosis. Nature 2000, 407, 233-241.
7. Libby, P., Aikawa, M., Schonbeck, U., Cholesterol and atherosclerosis. Biochim. Biophys. Acta 2000, 1529, 299-309.
8. Ruxton, C., Derbyshire, E., A systematic review of the association between cardiovascular risk factors and regular consumption of oats. Br. Food J. 2008, 110, 1119-1132.
9. Libby, P., Ridker, P. M., Hansson, G. K., Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473, 317-325.
10. Hansson, G. K., Hermansson, A., The immune system in atherosclerosis. Nat. Immunol. 2011, 12, 204-212.
11. Libby, P., Ridker, P. M., Hansson, G. K., Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 2009, 54, 2129-2138.
12. Chait, A., Han, Y. C., Oram, J. F., Heinecke, J. W., Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J. Lipid Res. 2005, 46, 389-403.
13. Balakumar, P., Kathuria, S., Taneja, G., Kalra, S. et al., Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? J. Mol. Cell. Cardiol. 2012, 52, 83-92.
14. Sitia, S., Tomasoni, L., Atzeni, F., Ambrosio, G. et al., From endothelial dysfunction to atherosclerosis. Autoimmun. Rev. 2010, 9, 830-834.
15. Zhou, M., Robards, K., Glennie-Holmes, M., Helliwell, S., Oat lipids. JAOCS 1999, 76, 159-169.
16. Ryan, D., Kendall, M., Robards, K., Bioactivity of oats as it relates to cardiovascular disease. Nutr. Res. Rev. 2007, 20, 147-162.
17. Drzikova, B., Dongowski, G, Gebhardt, E, Habel, A, The composition of dietary fibre-rich extrudates from oat affects bile acid binding and fermentation in vitro. Food Chem. 2005, 90, 181-192.
18. Peterson, D., Oat antioxidants. J. Cereal Sci. 2001, 33, 115-129.
19. Chen, C. Y., Milbury, P. E., Collins, F. W., Blumberg, J. B., Avenanthramides are bioavailable and have antioxidant activity in humans after acute consumption of an enriched mixture from oats. J. Nutr. 2007, 137, 1375-1382.
20. Chen, C. Y., Milbury, P. E., Kwak, H. K., Collins, F. W. et al., Avenanthramides and phenolic acids from oats are bioavailable and act synergistically with vitamin C to enhance hamster and human LDL resistance to oxidation. J. Nutr. 2004, 134, 1459-1466.
21. Koenig, R. T., Dickman, J. R., Wise, M. L., Ji, L. L., Avenanthramides are bioavailable and accumulate in hepatic, cardiac, and skeletal muscle tissue following oral gavage in rats. J. Agric. Food Chem. 2011, 59, 6438-6443.
22. Handelman, G. J., Cao, G., Walter, M. F., Nightingale, Z. D. et al., Antioxidant capacity of oat (Avena sativa L.) extracts. 1. Inhibition of low-density lipoprotein oxidation and oxygen radical absorbance capacity. J. Agric. Food Chem. 1999, 47, 4888-4893.
23. de Groot, A. P., Luyken, R., Pikaar, N. A., Cholesterol-lowering effects of rolled oats. Lancet 1963, 282, 303-304.
24. Brennan, C. S., Cleary, L. J., The potential use of cereal (1/3, 1/4)-b-D-glucans as functional food ingredients. J. Cereal Sci. 2005, 42, 1-13.
25. Kelly, S. A., Summerbell, C. D., Brynes, A., Whittaker, V. et al., Wholegrain cereals for coronary heart disease. Cochrane Database Syst. Rev. 2007, 18, CD005051.
26. Malkki, Y., Torronen, R., Pelkonen, K., Myllymaki, O. et al., Effects of oat-bran concentrate on rat serum lipids and liver fat infiltration. Br. J. Nutr. 1993, 70, 767-776.
27. De Schrijver, R., Fremaut, D., Verheyen, A., Cholesterol-lowering effects and utilization of protein, lipid, fiber and energy in rats fed unprocessed and baked oat bran. J. Nutr. 1992, 122, 1318-1324.
28. Delaney, B., Nicolosi, R. J., Wilson, T. A., Carlson, T. et al., Beta-glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters. J. Nutr. 2003, 133, 468-475.
29. Czerwinski, J., Bartnikowska, E., Leontowicz, H., Lange, E. et al., Oat (Avena sativa L.) and amaranth (Amaranthus hypochondriacus) meals positively affect plasma lipid profile in rats fed cholesterol-containing diets. J. Nutr. Biochem. 2004, 15, 622-629.
30. Andersson, K. E., Immerstrand, T., Sward, K., Bergenstahl, B. et al., Effects of oats on plasma cholesterol and lipoproteins in C57BL/6 mice are substrain specific. Br. J. Nutr. 2010, 103, 513-521.
31. Lund, E. K., Gee, J. M., Brown, J. C., Wood, P. J. et al., Effect of oat gum on the physical properties of the gastrointestinal contents and on the uptake of D-galactose and cholesterol by rat small intestine in vitro. Br. J. Nutr. 1989, 62, 91-101.
32. Andersson, M., Ellegard, L., Andersson, H., Oat bran stimulates bile acid synthesis within 8 h as measured by 7alpha-hydroxy-4-cholesten-3-one. Am. J. Clin. Nutr. 2002, 76, 1111-1116.
33. Yang, J. L., Kim, Y. H., Lee, H. S., Lee, M. S. et al., Barley beta-glucan lowers serum cholesterol based on the up-regulation of cholesterol 7alpha-hydroxylase activity and mRNA abundance in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. (Tokyo) 2003, 49, 381-387.
34. Wood, P. J., Braaten, J. T., Scott, F. W., Riedel, K. D. et al., Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. Br. J. Nutr. 1994, 72, 731-743.
35. Drzikova, B., Dongowski, G., Gebhardt, E., Dietary fibre-rich oat-based products affect serum lipids, microbiota, formation of short-chain fatty acids and steroids in rats. Br. J. Nutr. 2005, 94, 1012-1025.
36. Demigne, C., Morand, C., Levrat, M. A., Besson, C. et al., Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br. J. Nutr. 1995, 74, 209-219.
37. Levrat, M. A., Favier, M. L., Moundras, C., Remesy, C. et al., Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J. Nutr. 1994, 124, 531-538.
38. Immerstrand, T., Andersson, K. E., Wange, C., Rascon, A. et al., Effects of oat bran, processed to different molecular weights of beta-glucan, on plasma lipids and caecal formation of SCFA in mice. Br. J. Nutr. 2010, 104, 364-373.
39. Liu, S., Yang, N., Hou, Z., Yao, Y. et al., Antioxidant effects of oats avenanthramides on human serum. Agric. Sci. China 2011, 10, 1301-1305.
40. Charlton-Menys, V., Durrington, P. N., Human cholesterol metabolism and therapeutic molecules. Exp. Physiol. 2008, 93, 27-42.
41. Andersson, K. E., Svedberg, K. A., Lindholm, M. W., Oste, R. et al., Oats (Avena sativa) reduce atherogenesis in LDL-receptor-deficient mice. Atherosclerosis 2010, 212, 93-99.
42. Sur, R., Nigam, A., Grote, D., Liebel, F. et al., Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity. Arch. Dermatol. Res. 2008, 300, 569-574.
43. Theuwissen, E., Plat, J., Mensink, R. P., Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects. Mol. Nutr. Food Res. 2009, 53, 370-376.
44. Queenan, K. M., Stewart, M. L., Smith, K. N., Thomas, W. et al., Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr. J. 2007, 6, 6.
45. Libby, P., Ridker, P. M., Maseri, A., Inflammation and atherosclerosis. Circulation 2002, 105, 1135-1143.
46. Liu, L., Zubik, L., Collins, F. W., Marko, M. et al., The antiatherogenic potential of oat phenolic compounds. Atherosclerosis 2004, 175, 39-49.
47. Koga, T., Kwan, P., Zubik, L., Ameho, C. et al., Vitamin E supplementation suppresses macrophage accumulation and endothelial cell expression of adhesion molecules in the aorta of hypercholesterolemic rabbits. Atherosclerosis 2004, 176, 265-272.
48. Murray, P. J., Wynn, T. A., Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11, 723-737.
49. Woollard, K. J., Geissmann, F., Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 2010, 7, 77-86.
50. Thorp, E., Subramanian, M., Tabas, I., The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. Eur. J. Immunol. 2011, 41, 2515-2518.
51. Yun, C. H., Estrada, A., Van Kessel, A., Park, B. C. et al., Beta-glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections. FEMS Immunol. Med. Microbiol. 2003, 35, 67-75.
52. Zadernowski, R., Nowak-Polakowska, H., Rashed, A. A., The influence of heat treatment on the activity of lipo- and hydrophilic components of oat grain. J. Food Process. Preserv. 1999, 23, 177-191.
53. Singh, U., Devaraj, S., Jialal, I., Vitamin E, oxidative stress, and inflammation. Annu. Rev. Nutr. 2005, 25, 151-174.
54. Maki, K. C., Galant, R., Samuel, P., Tesser, J. et al., Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur. J. Clin. Nutr. 2007, 61, 786-795.
55. Gray, D. A., Clark, M. J., Baux, C., Bunting, J. P. et al., Antioxidant activity of oat extracts added to human LDL particles and in free radical trapping assays. J. Cereal Sci. 2002, 36, 209-218.
56. Emmons, C. L., Peterson, D. M., Antioxidant activity and phenolic contents of oat groats and hulls. Cereal Chem. 1999, 76, 902-906.
57. Ji, L. L., Lay, D., Chung, E., Fu, Y. et al., Effects of avenanthramides on oxidant generation and antioxidant enzyme activity in exercised rats. Nutr. Res. 2003, 23, 1579-1590.
58. Ren, Y., Yang, X., Niu, X., Liu, S. et al., Chemical characterization of the avenanthramide-rich extract from oat and its effect on D-galactose-induced oxidative stress in mice. J. Agric. Food Chem. 2011, 59, 206-211.
59. Lopez-Bote, C. J., Sanz, M., Rey, A., Castaño, A. et al., Lower lipid oxidation in the muscle of rabbits fed diets containing oats. Anim. Feed Sci. Technol. 1998, 70, 1-9.
60. Katz, D. L., Nawaz, H., Boukhalil, J., Giannamore, V. et al., Acute effects of oats and vitamin E on endothelial responses to ingested fat. Am. J. Prev. Med. 2001, 20, 124-129.
61. Kuhlencordt, P. J., Gyurko, R., Han, F., Scherrer-Crosbie, M. et al., Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001, 104, 448-454.
62. Nie, L., Wise, M. L., Peterson, D. M., Meydani, M., Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production. Atherosclerosis 2006, 186, 260-266.
63. Katz, D. L., Nawaz, H., Boukhalil, J., Chan, W. et al., Effects of oat and wheat cereals on endothelial responses. Prev. Med. 2001, 33, 476-484.
64. Katz, D. L., Evans, M. A., Chan, W., Nawaz, H. et al., Oats, antioxidants and endothelial function in overweight, dyslipidemic adults. J. Am. Coll. Nutr. 2004, 23, 397-403.
65. Keenan, J. M., Pins, J. J., Frazel, C., Moran, A. et al., Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial. J. Fam. Pract. 2002, 51, 369.
66. Saltzman, E., Das, S. K., Lichtenstein, A. H., Dallal, G. E. et al., An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J. Nutr. 2001, 131, 1465-1470.
67. Pins, J. J., Geleva, D., Keenan, J. M., Frazel, C. et al., Do whole-grain oat cereals reduce the need for antihypertensive medications and improve blood pressure control? J. Fam. Pract. 2002, 51, 353-359.
68. Meydani, M., Potential health benefits of avenanthramides of oats. Nutr. Rev. 2009, 67, 731-735.
69. Takahashi, A., Taniguchi, T., Ishikawa, Y., Yokoyama, M., Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53. Circ. Res. 1999, 84, 543-550.
70. Tamai, H., Katoh, K., Yamaguchi, T., Hayakawa, H. et al., The impact of tranilast on restenosis after coronary angioplasty: the Second Tranilast Restenosis Following Angioplasty Trial (TREAT-2). Am. Heart J. 2002, 143, 506-513.
71. Holmes, D. R., Jr., Savage, M., LaBlanche, J. M., Grip, L. et al., Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2002, 106, 1243-1250.
72. -/- mice. Pharmacol. Res. 2011, 64, 36-43.
73. Wilson, T. A., Idreis, H. M., Taylor, C. M., Nicolosi, R. J., Whole fat rice bran reduces the development of early aortic atherosclerosis in hypercholesterolemic hamsters compared with wheat bran. Nutr. Res. 2002, 22, 1319-1322.
74. Meir, K. S., Leitersdorf, E., Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1006-1014.
75. Cyrus, T., Yao, Y., Rokach, J., Tang, L. X. et al., Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions. Circulation 2003, 107, 521-523.
76. Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J. et al., Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N. Engl. J. Med. 2004, 350, 1495-1504.
77. Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D. et al., Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond. Circulation 2010, 121, 586-613.
78. Lopez-Garcia, E., Schulze, M. B., Fung, T. T., Meigs, J. B. et al., Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am. J. Clin. Nutr. 2004, 80, 1029-1035.
79. Erkkila, A. T., Herrington, D. M., Mozaffarian, D., Lichtenstein, A. H., Cereal fiber and whole-grain intake are associated with reduced progression of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease. Am. Heart J. 2005, 150, 94-101.
80. Trowell, H., Ischemic heart disease and dietary fiber. Am. J. Clin. Nutr. 1972, 25, 926-932.
81. Anderson, J. W., Hanna, T. J., Peng, X., Kryscio, R. J., Whole grain foods and heart disease risk. J. Am. Coll. Nutr. 2000, 19, 291S-299S.
82. Truswell, A. S., Cereal grains and coronary heart disease. Eur. J. Clin. Nutr. 2002, 56, 1-14.